a. Evolution in the number and co-circulation of dengue virus serotypes by month from Apr 2023-Sep 2024. b. Evolution in the number and co-circulation of dengue virus lineages by month from Apr 2023-Sep 2024.

a. Evolution in the number and co-circulation of dengue virus serotypes by month from Apr 2023-Sep 2024. b. Evolution in the number and co-circulation of dengue virus lineages by month from Apr 2023-Sep 2024.

<p>a. Evolution in the number and co-circulation of dengue virus serotypes by month from Apr 2023-Sep 2024. b. Evolution in the number and co-circulation of dengue virus lineages by month from Apr 2023-Sep 2024.</p>

Saved in:

Bibliographic Details
Main Author:	Daniela Torres-Hernández (22794582) (author)
Other Authors:	Nathan D. Grubaugh (7610039) (author), Mónica A. Murillo-Ortiz (22794585) (author), Isabel C. Hurtado (22794588) (author), Verity Hill (11063429) (author), Mallery I. Breban (10765921) (author), Mara Gómez-Zambrano (22794591) (author), Pio López (571992) (author), Erika Cantor (12416401) (author), Diana M. Dávalos (12416350) (author), Eduardo López-Medina (12416341) (author)
Published:	2025
Subjects:	Medicine Neuroscience Biotechnology Ecology Developmental Biology Cancer Infectious Diseases Virology Computational Biology Environmental Sciences not elsewhere classified whereas lower odds requiring blood transfusion predominantly affected children hospital active case virologically confirmed dengue severity risk factors risk factors described largest dengue epidemic independent risk factors including vascular leakage describe risk factors dengue infection showed 49 %) samples male ), serotyping finding cohort study dengue virus infection 145 dwws cases higher leukocyte counts detailed dengue classification 2023 &# 8211 28 %) patients serious dengue manifestations colombia </ p dengue virus serious manifestations higher risk severe dengue lymphocyte counts including 22 dengue occurred &# 8220 57 %) 32 %) 19 %) serious manifestation higher platelets xlink "> warning signs vcd ). unpredictable dynamics tetravalent protection significant effect severe course organ dysfunction living outside lineages 2ii_f identify patients frequent serotypes enrolling patients clinical data
Tags:	Add Tag No Tags, Be the first to tag this record!

Cannot write session to /tmp/vufind_sessions/sess_6dvsitp9euj9aoi869ppf2ckm0